Ingredion's $2.7 Billion Acquisition of Tate & Lyle Announced
Ingredion and Tate & Lyle have announced a significant agreement involving an all-cash acquisition deal valued at £2.7 billion. This transaction, which was confirmed on June 8, 2026, positions Ingredion to purchase Tate & Lyle at a premium, with shareholders receiving 595p per share, marking a nearly 59% increase compared to the closing price on May 13, 2026.
The acquisition, which awaits approval from Tate & Lyle’s shareholders, suggests an overall enterprise value of approximately £3.7 billion, equating to $5 billion. The companies have a shared goal of establishing a broader platform that leverages both firms' strengths, technical expertise, and international supply chains to better meet the evolving needs of consumers.
With this acquisition, Ingredion aims to expand its portfolio in areas such as texturants, sugar reduction, and fortification, thereby enhancing its capabilities in multi-ingredient systems and recipe development. Completion of the acquisition is anticipated in the second half of 2027, pending the approval process.
Jim Zallie, chairman, president, and CEO of Ingredion, stated that the merger would create a global leader in ingredient solutions, emphasizing the enhanced innovation expertise and geographic reach. The combined business is expected to offer better solutions for developing healthier and more affordable food products.
David Hearn, chair of Tate & Lyle, highlighted the company’s transformation over recent years into a leading global specialty food and beverage solutions business. He expressed optimism about the future potential of the combined entity, emphasizing the scope for increased investment in innovation.
The deal follows several earlier approaches by Ingredion, with Tate & Lyle confirming discussions last month. The proposed merger is set to bring together two industry powerhouses known for their complementary product offerings.
